Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 303K | $510K | $1.68 | Jan 31, 2024 | Direct |
Akebia Therapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to buy) | 455K | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | Jan 31, 2024 | 2 | $0 | 4 | Feb 2, 2024 | Chief Commercial Officer |
AKBA | Akebia Therapeutics, Inc. | Jan 8, 2024 | 0 | $0 | 3 | Jan 18, 2024 | Chief Commercial Officer |